Deferring Radiation Therapy for Brain Metastases in Patients With EGFR-Mutant Non-Small Cell Lung Cancer: A Multi-Institutional Analysis

被引：1

作者：

Magnuson, W. J. ^{[1
]}

Amini, A. ^{[2
]}

Patil, T. ^{[3
]}

Kavanagh, B. D. ^{[2
]}

Camidge, D. R. ^{[4
]}

Braunstein, S. E. ^{[5
]}

Boreta, L. ^{[5
]}

Attia, A. ^{[6
]}

Rana, N. ^{[6
]}

Contessa, J. N. ^{[1
]}

Gettinger, S. N. ^{[7
]}

Lester-Coll, N. H. ^{[1
]}

Yu, J. B. ^{[8
]}

Chiang, V. L. ^{[9
]}

机构：

[1] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA

[2] Univ Colorado Denver, Dept Radiat Oncol, Aurora, CO USA

[3] Univ Colorado, Dept Internal Med, Denver, CO 80202 USA

[4] Univ Colorado, Dept Med Oncol, Denver, CO 80202 USA

[5] Univ Calif San Francisco, San Francisco, CA 94143 USA

[6] Vanderbilt Univ, Med Ctr, Dept Radiat Oncol, Nashville, TN USA

[7] Yale Univ, Dept Med Oncol, New Haven, CT USA

[8] Yale Sch Med, Canc Outcomes Publ Policy & Effectiveness Res COP, New Haven, CT USA

[9] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期

关键词：

D O I：

10.1016/j.ijrobp.2016.06.149

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

128

引用

页码：S57 / S58

页数：2

共 50 条

[31] The Impact of Clinical and Molecular Profile of Resected EGFR-Mutant Non-Small Cell Lung Cancer on the Risk of Developing Brain Metastases
Moskovitz, M.
Cabanero, M.
Torchia, J.
Sorotsky, H.
Weiss, J.
Pintilie, M.
Leighl, N.
Bradbury, P.
Liu, G.
Zadeh, G.
Doherty, M.
Kia, A.
Torti, D.
Tsao, M.
Pugh, T.
Shepherd, F.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S1005 - S1006
[32] Management of EGFR-Mutant Non-Small Cell Lung Cancer: Focus on Gefitinib
Naito, Yoichi
Goto, Koichi
CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1027 - 1040
[33] Tackling Osimertinib Resistance in EGFR-Mutant Non-Small Cell Lung Cancer
Blaquier, Juan Bautista
Ortiz-Cuaran, Sandra
Ricciuti, Biagio
Mezquita, Laura
Cardona, Andres Felipe
Recondo, Gonzalo
CLINICAL CANCER RESEARCH, 2023, 29 (18) : 3579 - 3591
[34] Patritumab Deruxtecan Is Efficacious in EGFR-Mutant Non-Small Cell Lung Cancer
Zhang, H.
Yu, X.
Ye, J.
Li, H.
Hu, J.
Tan, Y.
CANCER DISCOVERY, 2023, 13 (12) : 2501 - 2501
[35] ctDNA for the Evaluation and Management of EGFR-Mutant Non-Small Cell Lung Cancer
Desai, Aakash
Vazquez, Tadana A.
Arce, Keishla M.
Corassa, Marcelo
Mack, Philip C.
Gray, Jhanelle E.
Pellini, Bruna
CANCERS, 2024, 16 (05)
[36] Effect of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors on Brain Metastases in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
Zhou, Qing
Zhang, Xuchao
Xu, Chongrui
Yang, Jinji
Yang, Xuening
An, Shejuan
Chen, Zhihong
Su, Jian
Wang, Binchao
Huang, Yisheng
Wang, Zhen
Huang, Yujuan
Wu, Yi-Long
JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S398 - S398
[37] Osimertinib in EGFR-mutant non-small cell lung carcinoma
Lorenz, Judith
PNEUMOLOGIE, 2023, 77 (11): : 847 - 847
[38] Upfront cranial radiotherapy for EGFR mutant non-small cell lung cancer with brain metastases
Kim, M. Y.
Kang, M. K.
RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S743 - S743
[39] Neurological Death is Common in Patients With EGFR Mutant Non-Small Cell Lung Cancer Diagnosed With Brain Metastases
Ramotar, Matthew
Barnes, Sierra
Moraes, Fabio
Dasgupta, Archya
Laperriere, Normand
Millar, Barbara-Ann
Berlin, Alejandro
Conrad, Tatiana
van Prooijen, Monique
Damyanovich, Andrei
Heaton, Robert
Cho, Young-Bin
Coolens, Catherine
Liu, Geoffrey
Shepherd, Frances A.
Bradbury, Penelope
Leighl, Natasha
Bernstein, Mark
Zadeh, Gelareh
Kongkham, Paul
Doherty, Mark
Shultz, David B.
ADVANCES IN RADIATION ONCOLOGY, 2020, 5 (03) : 350 - 357
[40] Radiation pneumonitis after concurrent aumolertinib and thoracic radiotherapy in EGFR-mutant non-small cell lung cancer patients
Yin, Hanjing
Jia, Wenxiao
Yu, Jinming
Zhu, Hui
BMC CANCER, 2024, 24 (01)

← 1 2 3 4 5 →